ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 235 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,730 | +33.5% | 11 | +22.2% | 0.00% | – |
| Q1 2024 | $3,543 | -37.9% | 9 | -40.0% | 0.00% | – |
| Q4 2023 | $5,706 | +16.1% | 15 | +50.0% | 0.00% | – |
| Q3 2023 | $4,916 | +26.1% | 10 | 0.0% | 0.00% | – |
| Q2 2023 | $3,897 | +4.6% | 10 | 0.0% | 0.00% | – |
| Q1 2023 | $3,726 | -45.4% | 10 | -44.4% | 0.00% | -100.0% |
| Q4 2022 | $6,819 | +70.5% | 18 | +63.6% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 11 | +37.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 8 | +33.3% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 6 | -64.7% | 0.00% | -100.0% |
| Q3 2021 | $5,000 | +25.0% | 17 | +41.7% | 0.00% | – |
| Q2 2021 | $4,000 | +100.0% | 12 | +71.4% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 7 | +16.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 6 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |